Archit Organosys Ltd (ARCHITORG) — shareholding pattern, promoter holding, financials and share price
About Archit Organosys Ltd (ARCHITORG)
Archit Organosys Ltd operates in the Commodity Chemicals industry, within the Chemicals sector. It trades on the NSE as ARCHITORG and on the BSE under scrip code 524640. Its ISIN is INE078I01011.
Incorporated in 1989, Archit Organosys Ltd does manufacturing and trading of chemicals and organics [1]
Archit Organosys Limited is engaged in manufacturing and trading of chemical products, primarily serving sectors like agrochemicals, pharmaceuticals, and cosmetics.
The company has expanded its international reach, with sales spanning the USA, Europe, Latin America, Asia, and South Africa, indicating a strong global presence.
Listed peers in Commodity Chemicals: Kanchi Karpooram Ltd, ARCL Organics Ltd, AG Ventures Ltd, Lead Reclaim and Rubber Products Ltd, Polychem Ltd.
Valuation & Returns
10 Jul 2026At ₹57.5 a share on 10 Jul 2026, Archit Organosys Ltd (ARCHITORG) was valued at a price-to-earnings ratio of 36.08x against an industry P/E of 45.11x and a price-to-book of 1.84x on a book value of ₹31.26 per share as of Mar 2024. Solomo computes return on equity of 5.1% and return on capital employed of 7.63% from filed results. Earnings ratios use consolidated results for the twelve months Jun 2023 to Mar 2024.
- P/E
- 36.08x
- Industry P/E
- 45.11x
- P/B
- 1.84x
- EPS (TTM)
- ₹1.59
- Book value / share
- ₹31.26
- ROE
- 5.1%
- ROCE
- 7.63%
- ROA
- 3.02%
- Debt / equity
- 0.41x
- Dividend yield
- 0.87%
- EBITDA margin
- 10.7%
- 52-week range
- ₹34 – ₹64.6
Ratios are computed from filed results and the last recorded price. Not investment advice.
Financial Performance
Mar 2024In the year ended Mar 2024, Archit Organosys Ltd (ARCHITORG) reported revenue of ₹113 crore, net profit of ₹3 crore and earnings per share of ₹1.6. That compares with revenue of ₹128 crore and net profit of ₹11 crore in Mar 2023. Figures are consolidated, as filed with the exchanges.
In the quarter ended Mar 2024, revenue was ₹30.99 crore and net profit ₹1.79 crore (consolidated).
| Metric | Mar 2007 | Mar 2008 | Mar 2022 | Mar 2023 | Mar 2024 |
|---|---|---|---|---|---|
| Revenue (₹ cr) | 19 | 21 | 138 | 128 | 113 |
| Net profit (₹ cr) | 0 | 0 | 8 | 11 | 3 |
| EPS (₹) | 0.39 | 0.41 | 4.01 | 5.53 | 1.6 |
| Measure | 10Y | 5Y | 3Y | 1Y |
|---|---|---|---|---|
| Sales growth | 10.28% | 10.37% | -3.07% | -11.42% |
| Profit growth | 14.74% | - | -15.02% | -71.10% |
| Stock price CAGR | 15% | 6% | 1% | 30% |
Ownership Summary
Jun 2026As of Jun 2026, promoters hold 65.88% of Archit Organosys Ltd (ARCHITORG) (unchanged from the previous quarter). Market capitalisation was ₹118 crore on 10 Jul 2026. Shareholding is filed quarterly with BSE and NSE; Solomo carries every filing back to Mar 2003.
Largest disclosed public shareholders in Jun 2026: HUF 2.04%, Shamoil Plumber 1.37%. Only stakes above the 1% disclosure threshold are named in filings.
| Quarter | Promoter | Pledged | FII | DII | Public |
|---|---|---|---|---|---|
| Jun 2026 | 65.88% | - | - | - | 34.12% |
| Mar 2026 | 65.88% | - | - | - | 34.12% |
| Dec 2025 | 65.86% | - | - | - | 34.14% |
| Sep 2025 | 65.39% | - | - | - | 34.61% |
| Jun 2025 | 65.39% | - | - | - | 34.61% |
| Mar 2025 | 65.3% | - | - | - | 34.7% |
| Dec 2024 | 64.84% | - | - | - | 35.16% |
| Sep 2024 | 64.65% | - | - | - | 35.35% |